Enavate Sciences GP, LLC
- SEC CIK
- 0001953107
- Latest filing
- Aug 14, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 7
- +1 vs. Q2 2025
- Portfolio value
- $327.5M
- +$151.0M (+85.5%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ZBIOZenas BioPharma, Inc. | COM | 3,761,359 | $83.5M | 25.5% | 00.0% | Unchanged | History |
| SIONSionna Therapeutics, Inc. | COM | 2,478,030 | $72.9M | 22.3% | 00.0% | Unchanged | History |
| IMNMImmunome Inc. | COM | 4,768,583 | $55.8M | 17.0% | 00.0% | Unchanged | History |
| UPBUpstream Bio, Inc. | COM | 2,459,703 | $46.3M | 14.1% | 00.0% | Unchanged | History |
| BBOTBridgeBio Oncology Therapeutics, Inc. | COM NEW | 2,626,946 | $30.4M | 9.3% | +2,626,946 | New | History |
| CMPXCompass Therapeutics, Inc. | COM | 7,788,150 | $27.3M | 8.3% | 00.0% | Unchanged | History |
| CAMPCamp4 Therapeutics Corp | COM | 3,785,802 | $11.4M | 3.5% | 00.0% | Unchanged | History |